The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes
Open accessAbstract
Children's Hospital Medical Center/Harvard Medical School, Boston, MA 021 15,' Institut fur Humangenetik und Genetische Poliklinik der Philipps-Universitat Marburg, Bahnhofstrasse 7A, West Germany,' Gladstone Foundation Laboratories, San Francisco, CA 94 140; Cardiovascular Research Institute, University of California, San Francisco, CA 941 43; Health Science Center, University of Texas, Dallas, T X 74235,5 Lipid Research Center, Washington University School of Medicine, St. Louis, M O 63110; Harborview Medical Center, Seattle, WA 98104; and Columbia College of Physicians and Surgeons, New York, NY 10032*
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The two genotypes combine into six common APOE genotypes, ε22, ε32, ε42, ε33, ε43 and ε44, corresponding to six plasma apoE phenotypes: apoE22, apoE32, apoE42, apoE33, apoE43 and apoE44 [14].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [14]
In the citing paper
“There are three common APOE alleles in the general population defined as: APOE ɛ2, APOE ɛ3, and APOE ɛ4 [2].”
From Discovery of a Missense Mutation (Q222K) of the APOE Gene from the Australian Imaging, Biomarker and Lifestyle Study (2023) · cites this paper as [2]
In the citing paper
“Apolipoprotein E (apoE) is one of the key apolipoproteins in blood lipid transport.”
From Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features (2025) · cites this paper as [1]
In the citing paper
“It has the following features: high hydrophobicity, the ability to bind to the low-density-lipoprotein (LDL) receptor and related receptors, production in various tissues throughout the body, acting as a central apoprotein of cerebrospinal fluid lipoproteins, having three major isoforms (apoE2, apoE3, and apoE4) that vary in their function and susceptibility to genetic mutations1).”
From Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features (2025) · cites this paper as [1]
In the citing paper
“It has the following features: high hydrophobicity, the ability to bind to the low-density-lipoprotein (LDL) receptor and related receptors, production in various tissues throughout the body, acting as a central apoprotein of cerebrospinal fluid lipoproteins, having three major isoforms (apoE2, apoE3, and apoE4) that vary in their function and susceptibility to genetic mutations1).”
From Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features (2025) · cites this paper as [1]
In the citing paper
“It has the following features: high hydrophobicity, the ability to bind to the low-density-lipoprotein (LDL) receptor and related receptors, production in various tissues throughout the body, acting as a central apoprotein of cerebrospinal fluid lipoproteins, having three major isoforms (apoE2, apoE3, and apoE4) that vary in their function and susceptibility to genetic mutations1).”
From Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features (2025) · cites this paper as [1]
In the citing paper
“It has the following features: high hydrophobicity, the ability to bind to the low-density-lipoprotein (LDL) receptor and related receptors, production in various tissues throughout the body, acting as a central apoprotein of cerebrospinal fluid lipoproteins, having three major isoforms (apoE2, apoE3, and apoE4) that vary in their function and susceptibility to genetic mutations1).”
From Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features (2025) · cites this paper as [1]
In the citing paper
“It has the following features: high hydrophobicity, the ability to bind to the low-density-lipoprotein (LDL) receptor and related receptors, production in various tissues throughout the body, acting as a central apoprotein of cerebrospinal fluid lipoproteins, having three major isoforms (apoE2, apoE3, and apoE4) that vary in their function and susceptibility to genetic mutations1).”
From Impact of Apolipoprotein E Variants: A Review of Naturally Occurring Variants and Clinical Features (2025) · cites this paper as [1]
Citations
Cites
Weisgraber, K. H., Rall, S. C., & Mahley, R. W. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52510-8 · Cited by 777
Self-citationPolymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man
UTERMANN, G., HEES, M., & STEINMETZ, A. (1977) · Nature · doi:10.1038/269604a0 · Cited by 666
Self-citationZannis, V. I., & Breslow, J. L. (1981) · Biochemistry · doi:10.1021/bi00507a059 · Cited by 563
Self-citationWindler, E. E. T., Kovanen, P. T., Chao, Y. S., Brown, M. S., Havel, R. J., & Goldstein, J. L. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70487-6 · Cited by 456
Self-citationInnerarity, T. L., & Mahley, R. W. (1978) · Biochemistry · doi:10.1021/bi00601a013 · Cited by 433
Self-citationSherrill, B. C., Innerarity, T. L., & Mahley, R. W. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85951-3 · Cited by 426
Self-citationDeterminants of hepatic uptake of triglyceride-rich lipoproteins and their remnants in the rat.
Windler, E. E. T., Chao, Y. S., & Havel, R. J. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70811-4 · Cited by 365
Self-citationWindler, E., Chao, Y., & Havel, R. J. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70647-4 · Cited by 365
Self-citationEffect of apoproteins on hepatic uptake of triglyceride emulsions in the rat.
Shelburne, F. A., Hanks, J., Meyers, W., & Quarfordt, S. H. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109710 · Cited by 358
(1981) · PubMed · Cited by 341
Self-citation
Research works printed but not linked: 2
- Utermann, G., A. Steinmetz, and W. Weber. 1982. Polymorphism of human apolipoprotein E: genetic control and gene frequencies. Am. J. Hum. Genet. In press.
- Sherrill, 1980, Addition of E-apoprotein to cholesterol-rich fluorescent lipid dispersion increases liver recognition and uptake, Circulation., 62, 44
Cited by
Sorted by citations
Items 101–200 of 435
The Involvement of Lipids in Alzheimer's Disease
Lim, W. L. F., Martins, I. J., & Martins, R. N. (2014) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2014.04.003 · Cited by 67
Kao, J., Tsai, K., Chang, C., & Huang, P. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05464-t · Cited by 63
Association of apolipoprotein (Apo)E genotype with plasma apo E levels
Larson, I. A., Ordovás, J. M., DeLuca, C., Barnard, J. R., Feussner, G., & Schaefer, E. J. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00280-4 · Cited by 64
Influence of APOE Genotype on Hippocampal Atrophy over Time - An N=1925 Surface-Based ADNI Study
Li, B., Shi, J., Gutman, B. A., Baxter, L. C., Thompson, P. M., Caselli, R. J., Wang, Y., & Initiative, A. D. N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152901 · Cited by 67
Jasieńska, G., Ellison, P. T., Galbarczyk, A., Jasieński, M., Kalemba-Drożdż, M., Kapiszewska, M., Nenko, I., Thune, I., & Ziomkiewicz, A. (2015) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2014.2395 · Cited by 64
Eto, M., Watanabe, K., & Ishii, K. (1985) · Clinica Chimica Acta · doi:10.1016/0009-8981(85)90269-4 · Cited by 42
Apolipoprotein E polymorphism in cerebrovascular & coronary heart diseases.
Shajith Anoop, S., Misra, A., Meena, K., & Luthra, K. (2010) · PubMed · Cited by 60
A Dietary Treatment Improves Cerebral Blood Flow and Brain Connectivity in Aging apoE4 Mice
Wiesmann, M., Zerbi, V., Jansen, D., Haast, R., Lütjohann, D., Broersen, L. M., Heerschap, A., & Kiliaan, A. J. (2016) · Neural Plasticity · doi:10.1155/2016/6846721 · Cited by 60
Type 2 diabetes mellitus in the pathophysiology of Alzheimer's disease
de Nazareth, A. M. (2017) · Dementia & Neuropsychologia · doi:10.1590/1980-57642016dn11-020002 · Cited by 64
Filou, S., Lhomme, M., Karavia, E. A., Kalogeropoulou, C. P., Theodoropoulos, V., Zvintzou, E., Sakellaropoulos, G. C., Πετροπούλου, Π.-Ι., Constantinou, C., Kontush, A., et al. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00389 · Cited by 60
Intracellular modifications of human apolipoprotein E.
Zannis, V. I., vanderSpek, J. C., & Silverman, D. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67033-4 · Cited by 57
Self-citationSeventeen Years of Statin Pharmacogenetics: a Systematic Review
Leusink, M., Onland‐Moret, N. C., de Bakker, P. I. W., de Boer, A., & der Zee, A. H. M. (2015) · Pharmacogenomics · doi:10.2217/pgs.15.158 · Cited by 56
EXERCISE IN THE TREATMENT OF LIPID DISORDERS
Durstine, J. L., & Thompson, P. D. (2001) · Cardiology Clinics · doi:10.1016/s0733-8651(05)70230-7 · Cited by 55
[49] Genetic polymorphism in human apolipoprotein E
Zannis, V. I. (1986) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(86)28109-4 · Cited by 55
Self-citationApoE4 attenuates autophagy via FoxO3a repression in the brain
Sohn, H.-Y., Kim, S.-I., Park, J.-Y., Park, S.-H., Koh, Y. H., Kim, J., & Jo, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-97117-6 · Cited by 54
Blom, D. J., Byrnes, P., Jones, S., & Marais, A. D. (2003) · Journal of Lipid Research · doi:10.1194/jlr.d200013-jlr200 · Cited by 54
Mercury, APOE, and children's neurodevelopment
Ng, S., Lin, C., Hwang, Y., Hsieh, W., Liao, H., & Chen, P. (2013) · NeuroToxicology · doi:10.1016/j.neuro.2013.03.012 · Cited by 54
Pathogenesis of hyperlipoproteinemia
Grundy, S. M. (1984) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34439-4 · Cited by 54
Landén, M., Thorsell, A., Wallin, A., & Blennow, K. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.61.4.352 · Cited by 55
Chang, D. J., Paik, Y., Leren, T. P., Walker, D., Howlett, G. J., & Taylor, J. M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38877-5 · Cited by 54
Apolipoprotein E: Remarkable Protein Sheds Light on Cardiovascular and Neurological Diseases
Mahley, R. W. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2016.255695 · Cited by 53
Self-citationPouliot, M. C., Després, J., Moorjani, S., Lupien, P., Tremblay, A., & Bouchard, C. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42742-7 · Cited by 52
Variation at APOE and STH loci and Alzheimer's disease
Zuo, L., van Dyck, C. H., Luο, X., Kranzler, H. R., Yang, B., & Gelernter, J. E. (2006) · Behavioral and Brain Functions · doi:10.1186/1744-9081-2-13 · Cited by 51
Apolipoprotein E2, renal failure and lipid abnormalities in non-insulin-dependent diabetes mellitus
Horita, K., Eto, M., & Makino, I. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90021-3 · Cited by 50
Biochemical analysis of cell-derived apoE3 particles active in stimulating neurite outgrowth
Demattos, R. B., Rudel, L. L., & Williams, D. L. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31622-9 · Cited by 48
Chapter 14 Apolipoprotein E in nerve injury and repair
Ignatius, M. J., Gebicke‐Haerter, P. J., Pitas, R. E., & Shooter, E. M. (1987) · Progress in brain research · doi:10.1016/s0079-6123(08)61822-1 · Cited by 51
Apolipoprotein E4 has extensive conformational heterogeneity in lipid-free and lipid-bound forms
Stuchell-Brereton, M. D., Zimmerman, M. I., Miller, J. J., Mallimadugula, U. L., Incicco, J. J., Roy, D., Smith, L. G., Cubuk, J., Baban, B., DeKoster, G. T., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2215371120 · Cited by 48
Karavia, E. A., Papachristou, D. J., Kotsikogianni, I., Giopanou, I., & Kypreos, K. E. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08238.x · Cited by 47
Apolipoprotein E polymorphism in the Greek population
Sklavounou, E., Economou-Petersen, E., Karadima, G., Πάνας, Μ., Avramopoulos, D., Varsou, A., Vassilopoulos, D., & Petersen, M. B. (1997) · Clinical Genetics · doi:10.1111/j.1399-0004.1997.tb02550.x · Cited by 44
A multi‐hit hypothesis for an APOE4 ‐dependent pathophysiological state
Steele, O. G., Stuart, A. C., Minkley, L., Shaw, K., Bonnar, O., Anderle, S., Penn, A. C., Rusted, J., Serpell, L., Hall, C., et al. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15685 · Cited by 44
LilrB3 is a putative cell surface receptor of APOE4
Zhou, J., Wang, Y., Huang, G., Yang, M., Zhu, Y., Jin, C., Jing, D., Ji, K., & Shi, Y. (2023) · Cell Research · doi:10.1038/s41422-022-00759-y · Cited by 44
Impact of apolipoprotein E genetic polymorphisms on liver disease: An essential review
Nascimento, J. C. R., Matos, G. A., Pereira, L. C., Mourão, A. E. C. C. B., Sampaio, A. M., Oriá, R. B., & Toniutto, P. (2019) · Annals of Hepatology · doi:10.1016/j.aohep.2019.07.011 · Cited by 44
Dallongeville, J., Roy, M., LeBoeuf, N. R., Xhignesse, M., Davignon, J., & Lussier‐Cacan, S. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.2.272 · Cited by 44
Apolipoprotein E phenotypes in patients with gout: relation with hypertriglyceridaemia.
Moriwaki, Y., Yamamoto, T., Takahashi, S., Tsutsumi, Z., & Higashino, K. (1995) · Annals of the Rheumatic Diseases · doi:10.1136/ard.54.5.351 · Cited by 44
Adenosine receptor signalling in Alzheimer’s disease
Trinh, P. N. H., Baltos, J., Hellyer, S. D., May, L. T., & Gregory, K. J. (2022) · Purinergic Signalling · doi:10.1007/s11302-022-09883-1 · Cited by 43
Basaly, V., Hill, J., Bihaqi, S. W., Marques, E., Slitt, A. L., & Zawia, N. H. (2021) · NeuroToxicology · doi:10.1016/j.neuro.2021.06.008 · Cited by 41
Underexpression of the apolipoprotein E2 and E4 alleles in the Greek Cypriot population of Cyprus
Cariolou, M. A., Kokkofitou, A., Manoli, P., Christou, S., Karagrigoriou, A., & Middleton, L. T. (1995) · Genetic Epidemiology · doi:10.1002/gepi.1370120506 · Cited by 39
Weisgraber, K. H., Newhouse, Y. M., & Mahley, R. W. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81003-9 · Cited by 39
Self-citationXu, C., Talmud, P. J., Angelico, F., Ben, M. D., Savill, J., Humphries, S. E., & Vogler, G. P. (1991) · Genetic Epidemiology · doi:10.1002/gepi.1370080605 · Cited by 39
Seripa, D., Matera, M. G., Daniele, A., Bizzarro, A., Rinaldi, M., Gravina, C., Bisceglia, L., Corbo, R. M., Panza, F., Solfrizzi, V., et al. (2007) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2006.00344.x · Cited by 38
Yin, R., Pan, S., Wu, J., Lin, W., & Dezhai, Y. (2008) · Experimental Biology and Medicine · doi:10.3181/0709-rm-254 · Cited by 38
Apolipoprotein E gene polymorphism and gender.
Kolovou, G. D., Damaskos, D., Anagnostopoulou, K. K., & Cokkinos, D. V. (2009) · PubMed · Cited by 38
Mapping genetic influences on ventricular structure in twins
CHOU, Y., Leporé, N., Chiang, M. Y.-H., Avedissian, C., Marina Barysheva, A., McMahon, K. L., de Zubicaray, G. I., Meredith, M., Wright, M. J., & Toga, A. W. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.10.036 · Cited by 38
Concerning the structure of apoE
Frieden, C., & Garai, K. (2013) · Protein Science · doi:10.1002/pro.2379 · Cited by 39
Lipoprotein Transport Gene Abnormalities Underlying Coronary Heart Disease Susceptibility
Breslow, J. L. (1991) · Annual Review of Medicine · doi:10.1146/annurev.me.42.020191.002041 · Cited by 38
Self-citationEfficiency of intestinal cholesterol absorption in humans is not related to apoE phenotype
von Bergmann, K., Lütjohann, D., Lindenthal, B., & Steinmetz, A. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200319-jlr200 · Cited by 38
Georgiadou, D., Stamatakis, K., Efthimiadou, E. K., Kordas, G., Gantz, D., Chroni, A., & Stratikos, E. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m030965 · Cited by 37
APOE4 predicts amyloid-β in cortical brain biopsy but not idiopathic normal pressure hydrocephalus
Pyykkö, O. T., Helisalmi, S., Koivisto, A. M., Mölsä, J. A. A., Rummukainen, J. K., Nerg, O., Alafuzoff, I. I., Savolainen, S., Soininen, H. S., Jääskeläinen, J. E., et al. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-303849 · Cited by 38
Setzer, M., Hermann, E. J., Seifert, V., & Marquardt, G. (2008) · Spine · doi:10.1097/brs.0b013e3181657cf7 · Cited by 37
Setzer, M., Vrionis, F. D., Hermann, E. J., Seifert, V., & Marquardt, G. (2009) · Journal of Neurosurgery Spine · doi:10.3171/2009.7.spine08667 · Cited by 37
Hackler, R., Schäfer, J., Motzny, S., Brand, S., Kleine, T. O., Kaffarnik, H., & Steinmetz, A. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40122-1 · Cited by 37
Mercury, APOE, and child behavior
Ng, S., Lin, C., Jeng, S., Hwang, Y., Hsieh, W., & Chen, P. (2014) · Chemosphere · doi:10.1016/j.chemosphere.2014.06.003 · Cited by 36
Apolipoprotein E and protection against hepatitis E viral infection in American non‐Hispanic blacks
Zhang, L., Yesupriya, A., Chang, M., Teshale, E. H., & Teo, C. (2015) · Hepatology · doi:10.1002/hep.27938 · Cited by 36
Apolipoprotein E in Cerebrospinal Fluid in 85-Year-Old Subjects
Skoog, I. G. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550150029012 · Cited by 35
Phenotyping of human apolipoprotein E from whole blood plasma by immunoblotting
Steinmetz, A. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38599-0 · Cited by 36
Apolipoprotein E Gene Polymorphism in Nonalcoholic Fatty Liver Disease
Demirağ, M. D., Önen, H. İ., Karaoğuz, M. Y., Doğan, İ., Karakan, T., Ekmekçi, A., & Güz, G. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-9740-5 · Cited by 36
The neurobiology of APOE in schizophrenia and mood disorders
Gibbons, A. S. (2010) · Frontiers in bioscience · doi:10.2741/3729 · Cited by 35
Lim, W. L. F., Lam, S. M., Shui, G., Mondal, A., Ong, D., Duan, X., Creegan, R., Martins, I. J., Sharman, M. J., Taddei, K., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.03.012 · Cited by 37
O'Dwyer, L., Lamberton, F., Matura, S., Scheibe, M., Miller, J., Rujescu, D., Prvulovic, D., & Hampel, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036024 · Cited by 34
Isoform-specific effects of apoE on neurite outgrowth in olfactory epithelium culture
Hussain, A., Luong, M., Pooley, A., & Nathan, B. P. (2013) · Journal of Biomedical Science · doi:10.1186/1423-0127-20-49 · Cited by 34
Blennow, K., & Vanmechelen, E. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6467-9_20 · Cited by 35
Secretion of Apolipoprotein E by Basal Cells in Cultures of Epidermal Keratinocytes
Barra, R. M., Fenjves, E. S., & Taichman, L. B. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12371733 · Cited by 33
Kloske, C. M., Belloy, M. E., Blue, E. E., Bowman, G. R., Carrillo, M. C., Chen, X., Chiba‐Falek, O., Davis, A. A., Paolo, G. D., Garretti, F., et al. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13877 · Cited by 33
Ayers, K. L., Mirshahi, U. L., Wardeh, A. H., Murray, M. F., Hao, K., Glicksberg, B. S., Li, S., Carey, D. J., & Chen, R. (2016) · BMC Genomics · doi:10.1186/s12864-016-2725-z · Cited by 32
Apolipoprotein E in Cardiovascular Diseases: Novel Aspects of an Old-fashioned Enigma
Liehn, E. A., Ponomariov, V., Diaconu, R., Streață, I., Ioana, M. I., Crespo-Avilan, G. E., Hernández‐Reséndiz, S., & Cabrera-Fuentes, H. A. (2018) · Archives of Medical Research · doi:10.1016/j.arcmed.2018.08.008 · Cited by 30
Wang, C., Yan, W., Wang, H., Zhu, J., & Chen, H. (2019) · Pharmacogenomics · doi:10.2217/pgs-2019-0048 · Cited by 35
Suzuki, K., Hirakawa, A., Ihara, R., Iwata, A., Ishii, K., Ikeuchi, T., Sun, C., Donohue, M., Iwatsubo, T., & Alzheimer's Disease Neuroimaging Initiative, J. A. D. N. I. (2020) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12007 · Cited by 32
Association of apolipoprotein ɛ4 allele with hypertriglyceridemia in obesity
Fumeron, F., Rigaud, D., Bertiere, M. C., Bardon, S., Dely, C., & Apfelbaum, M. (1988) · Clinical Genetics · doi:10.1111/j.1399-0004.1988.tb02873.x · Cited by 33
Apolipoprotein AIMarburg: Studies on two kindreds with a mutant of human apolipoprotein AI
Utermann, G., Steinmetz, A., PAETZOLD, R., Wilk, J., Feussner, G., Kaffarnik, H., Mueller-Eckhardt, C., Seidel, D., Vogelberg, K. H., & Zimmer, F. (1982) · Human Genetics · doi:10.1007/bf00276597 · Cited by 33
Self-citationMolecular genetic epidemiology of age-related hearing impairment
Uchida, Y., Sugiura, S., Ando, F., Nakashima, T., & Shimokata, H. (2011) · Auris Nasus Larynx · doi:10.1016/j.anl.2011.02.005 · Cited by 34
Genetic Variability in Molecular Pathways Implicated in Alzheimer's Disease: A Comprehensive Review
Vogrinc, D., Goričar, K., & Dolžan, V. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.646901 · Cited by 32
Madrid, L., Initiative, A. D. N., Moreno–Grau, S., Ahmad, S., González-Pérez, A., de Rojas, I., Xia, R., Adami, P. V. M., García‐González, P., Kleineidam, L., et al. (2021) · Aging · doi:10.18632/aging.202950 · Cited by 33
Dafnis, I., Tzinia, A. K., Tsilibary, E. C., Zannis, V. I., & Chroni, A. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.03.013 · Cited by 32
Self-citationSeripa, D., Signori, E., Gravina, C., Matera, M. G., Rinaldi, M., & Fazio, V. M. (2006) · Diagnostic Molecular Pathology · doi:10.1097/01.pdm.0000213451.99655.1d · Cited by 31
Functionally inactive apolipoprotein E3 in a type III hyperlipoproteinaemic patient
HAVEKES, L. M., LEUVEN, J. A. G., CORVEN, E. V., WIT, E. D., & EMEIS, J. J. (1984) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1984.tb00696.x · Cited by 31
Apolipoprotein E is an HIV-1-inducible inhibitor of viral production and infectivity in macrophages
Siddiqui, R., Suzu, S., Ueno, M., Nasser, H., Koba, R., Bhuyan, F., Noyori, O., Hamidi, S., Sheng, G., Yasuda-Inoue, M., et al. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007372 · Cited by 31
Lipogenic effects of psychotropic drugs: focus on the SREBP system
Fernø, J. (2010) · Frontiers in bioscience · doi:10.2741/3675 · Cited by 33
DeMattos, R. B., Thorngate, F. E., & Williams, D. L. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-07-02464.1999 · Cited by 30
Clinical chemistry of common apolipoprotein E isoforms
Dijck-Brouwer, J., van Doormaal, J. J., & Muskiet, F. A. J. (1996) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/0378-4347(95)00256-1 · Cited by 30
Kane, J. W., & Gowland, E. (1986) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456328602300504 · Cited by 29
Bamji, A. N. (2003) · British journal of rheumatology · doi:10.1093/rheumatology/keg166 · Cited by 29
Plasma apolipoprotein B metabolism in familial type III dysbetalipoproteinaemia
TURNER, P. R., Cortese, C., Wootton, R., Marenah, C. B., Miller, N. E., & Lewis, B. (1985) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1985.tb00152.x · Cited by 28
Apolipoprotein E deficiency with a depressed mRNA of normal size
KUROSAKA, D., TERAMOTO, T., MATSUSHIMA, T., YOKOYAMA, T., YAMADA, A., AIKAWA, T., MIYAMOTO, Y., & KUROKAWA, K. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90252-x · Cited by 37
Therapeutic potential of ApoE-mimetic peptides in CNS disorders: Current perspective
Ahmed, S., Pande, A. H., & Sharma, S. S. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114051 · Cited by 29
Sleep–Wake Disorders in Alzheimer’s Disease: A Review
Sun, Y.-Y., Wang, Z., Zhou, H.-Y., & Huang, H. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00097 · Cited by 27
Protective effect of the apo ɛ2 allele in major depressive disorder in Taiwanese
Fan, P., Chen, C. ‐., Kao, W.-T., Shu, B., & Lung, F. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00686.x · Cited by 27
Borghini, I., James, R. W., Blatter, M.-C., & Pometta, D. (1991) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(91)90034-f · Cited by 21
Isolation and characterization of several plasma apolipoproteins of common marmoset monkey.
Crook, D., Weisgraber, K. H., Rall, S. C., & Mahley, R. W. (1990) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.10.4.625 · Cited by 27
Self-citationSteinmetz, A., Assefbarkhi, N., Eltze, C., Ehlenz, K., Funke, H., Pies, A., Assmann, G., & Kaffarnik, H. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42740-3 · Cited by 27
de Smit, M. H., van der Kooij-Meijs, E., Woudt, L. P., Havekes, L. M., & Frants, R. R. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80424-8 · Cited by 27
Molecular Biology of Human Apolipoproteins B and E and Associated Diseases of Lipoprotein Metabolism
Zannis, V. I. (1989) · Advances in lipid research · doi:10.1016/b978-0-12-024923-7.50005-4 · Cited by 26
Self-citationRole of Apolipoprotein E in Alzheimer’s Disease
Zannis, V. I., Zanni, E. E., Makrides, S. C., Kardassis, D., & Aleshkov, S. B. (1998) · Springer eBooks · doi:10.1007/978-1-4899-0133-0_13 · Cited by 26
Self-citationLack of influence of apolipoprotein E4 on lipoprotein levels in the island population of Sardinia
Deiana, Pes, G. M., Carru, C., Errigo, A., Pettinato, Carcassi, C., 박기오, & Contu (1998) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1998.00271.x · Cited by 26
Hesse, C., Bogdanović, N., Davidsson, P., & Blennow, K. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017189 · Cited by 26
Walden, C. C., Huff, M. W., Leiter, L. A., Connelly, P. W., & Hegele, R. A. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.3.7907341 · Cited by 26
Williams, P., Dreon, D. M., & Krauss, R. M. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.6.1234 · Cited by 26
Relationship between apolipoprotein E and low density lipoprotein particle size
Zhao, S., Verhoeven, M. H., Vink, J., Hollaar, L., van der Laarse, A., de Knijff, P., & Hooft, F. M. V. '. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90156-o · Cited by 26
Okoro, E. U., Zhao, Y., Guo, Z., Zhou, L., Lin, X., & Yang, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044430 · Cited by 25
Olivecrona, M., Wildemyr, Z., & Koskinen, L. (2009) · Journal of neurosurgery · doi:10.3171/2009.8.jns09636 · Cited by 26
İşbir, T., Ağaçhan, B., Yılmaz, H., Aydın, M., Kara, İ., Eker, D., & Eker, E. (2001) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750101600407 · Cited by 24
Metadata
- Authors
- Zannis, V. I., Breslow, J. L., Utermann, G., Mahley, R. W., Weisgraber, K. H., Havel, R. J., Goldstein, J. L., Brown, M. S., Schonfeld, G., Hazzard, W. R., & Blum, C.
- Affiliations
- Harvard University (US)
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 1982-08
- Volume
- 23
- Issue
- 6
- Pages
- 911-914
- ISSN
- 0022-2275 (ISSN-L)
- OpenAlex
- W1770880387
- Cited by
- 436
- References
- 31
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 5 · 2023: 15 · 2022: 8 · 2021: 12 · 2020: 4 · 2019: 4 · 2018: 7 · 2017: 7 · 2016: 9 · 2015: 12 · 2014: 15 · 2013: 11 · 2012: 11
- FWCI
- 25.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- apolipoprotein E, APOE genotype, nomenclature, genetic variants, lipoprotein metabolism
- MeSH terms
- Apolipoproteins, Apolipoproteins E, Genotype, Humans, Terminology as Topic, Phenotype
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
